SK

Sanjay Kumar Singh

Active Director Director DIN 00696305
DIN 00696305 First appointment Mar 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Mar 2013
Shareholding value •••• Premium profile

About Sanjay Kumar Singh

Data last updated:

Sanjay Kumar Singh is a Director at Massmed Private Limited (since 2018), Director at Neonectar Private Limited (since 2022) and Director at Oneextramiles Tours Private Limited (since 2013), and holds 2 more current directorships. The companies operate in Healthcare, Information Technology and Machinery and Equipment. The 3 current companies with reported revenue have a combined latest revenue of ₹16.04 Cr; the largest is Massmed Private Limited at ₹12.01 Cr (FY 2025). Earlier, Sanjay Kumar Singh was a Director at Acura Biotech Private Limited (from 2014).

DIN 00696305
Primary Designation Director
Industry Healthcare
First Appointment 26 Mar 2013
Oldest Company Age 13 yrs
Largest company Massmed Private Limited · ₹12.01 Cr (FY 2025)
Combined revenue ₹16.04 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Massmed Private Limited U51900GJ2018PTC102571
Director29 May 20182018₹12.01 Cr (FY 2025)Active
Neonectar Private Limited U72900DL2022PTC401473
Director08 Jul 20222022₹2.15 Cr (FY 2025)Active
Oneextramiles Tours Private Limited U63000DL2013PTC249897
Director26 Mar 20132013₹1.88 Cr (FY 2025)Active
Vitam Healthcare Private Limited U85100DL2013PTC257327
Director07 Sep 20132013Active
Director02 Dec 20132013Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acura Biotech Private Limited U85190DL2014PTC264444
Director04 Feb 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Massmed Private Limited
Oneextramiles Tours Private Limited
Red Marketing Services Private Limited
Neonectar Private Limited
Premium access

Shareholding and investment profile for Sanjay Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kumar Singh

Sanjay Kumar Singh currently holds 5 directorships: Massmed Private Limited (Director, since 29 May 2018, revenue ₹12.01 Cr (FY 2025)); Neonectar Private Limited (Director, since 08 Jul 2022, revenue ₹2.15 Cr (FY 2025)); Oneextramiles Tours Private Limited (Director, since 26 Mar 2013, revenue ₹1.88 Cr (FY 2025)); Vitam Healthcare Private Limited (Director, since 07 Sep 2013); Red Marketing Services Private Limited (Director, since 02 Dec 2013).

Sanjay Kumar Singh was first appointed on 26 Mar 2013 as Director at Oneextramiles Tours Private Limited. The most recent appointment on record is 08 Jul 2022 at Neonectar Private Limited.

The 3 current companies of Sanjay Kumar Singh that report revenue have a combined latest revenue of ₹16.04 Cr: Massmed Private Limited ₹12.01 Cr (FY 2025); Neonectar Private Limited ₹2.15 Cr (FY 2025); Oneextramiles Tours Private Limited ₹1.88 Cr (FY 2025).

Sanjay Kumar Singh held 1 earlier board appointment: Acura Biotech Private Limited (Director, from 04 Feb 2014).

The current boards of Sanjay Kumar Singh's companies include Anurag Dhanjibhai Borad (Massmed Private Limited), Mihir Manojbhai Shah (Massmed Private Limited), Sandeep Ranjan (Massmed Private Limited), Soni Singh (Neonectar Private Limited), Anil Walia (Oneextramiles Tours Private Limited), Guriqbal Singh Walia (Red Marketing Services Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available